We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+3.85%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$42.9B
AUM Growth
+$349M
(+0.82%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
921
New
30
Increased
236
Reduced
381
Closed
55
Avg Time Held
2.7
quarters
Top 10 Avg Time Held
2.4
quarters
Top 20 Avg Time Held
2.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$516M |
| 2 |
Exelon
EXC
|
+$216M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
Baxter International
BAX
|
+$52.2M |
| 5 |
Intel
INTC
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$189M |
| 2 |
Walgreens Boots Alliance
WBA
|
+$162M |
| 3 |
Merck
MRK
|
+$116M |
| 4 |
Abbott
ABT
|
+$79.3M |
| 5 |
HAR
Harman International Industries
HAR
|
+$75.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.88% |
| 2 | Technology | 15.18% |
| 3 | Energy | 12.54% |
| 4 | Healthcare | 12.19% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$162B
| $1.04B | 2.43% |
34,224,581
+4,849,128
| +17% | +$145M |
2013 Q2
3 quarters
|
|
2
Chevron
CVX
$422B
| $971M | 2.26% |
8,163,140
-272,603
| -3% | -$31.7M |
2013 Q2
3 quarters
|
|
3
ExxonMobil
XOM
$707B
| $910M | 2.12% |
9,313,610
-313,663
| -3% | -$29.9M |
2013 Q2
3 quarters
|
|
4
JPMorgan Chase
JPM
$888B
| $888M | 2.07% |
14,625,400
-647,079
| -4% | -$37.4M |
2013 Q2
3 quarters
|
|
5
Wells Fargo
WFC
$253B
| $823M | 1.92% |
16,543,868
-724,341
| -4% | -$33.7M |
2013 Q2
3 quarters
|
|
6
Cisco
CSCO
$454B
| $625M | 1.46% |
27,881,028
-680,132
| -2% | -$15M |
2013 Q2
3 quarters
|
|
7
ConocoPhillips
COP
$164B
| $579M | 1.35% |
8,226,503
-298,688
| -4% | -$20M |
2013 Q2
3 quarters
|
|
|
8
AT&T
T
$154B
| $573M | 1.34% |
21,630,290
+20,536,295
| +1,877% | +$516M |
2013 Q2
3 quarters
|
|
|
9
Intel
INTC
$535B
| $554M | 1.29% |
21,461,473
+1,742,554
| +9% | +$43.5M |
2013 Q2
3 quarters
|
|
10
Amgen
AMGN
$224B
| $491M | 1.15% |
3,984,907
-141,623
| -3% | -$17.2M |
2013 Q2
3 quarters
|
|
11
Northrop Grumman
NOC
$68.7B
| $477M | 1.11% |
3,868,799
-230,850
| -6% | -$27.4M |
2013 Q2
3 quarters
|
|
12
Elevance Health
ELV
$91.4B
| $474M | 1.11% |
4,762,883
-17,641
| -0.4% | -$1.6M |
2013 Q2
3 quarters
|
|
13
Citigroup
C
$220B
| $467M | 1.09% |
9,810,535
-589,749
| -6% | -$29.4M |
2013 Q2
3 quarters
|
|
14
Deere & Co
DE
$169B
| $451M | 1.05% |
4,969,695
-94,433
| -2% | -$8.26M |
2013 Q2
3 quarters
|
|
15
Kroger
KR
$36.6B
| $440M | 1.02% |
20,139,478
-522,124
| -3% | -$10.4M |
2013 Q2
3 quarters
|
|
16
Ameriprise Financial
AMP
$44.3B
| $439M | 1.02% |
3,990,730
-261,432
| -6% | -$28.6M |
2013 Q2
3 quarters
|
|
17
Oracle
ORCL
$416B
| $435M | 1.01% |
10,631,531
+24,669
| +0.2% | +$939K |
2013 Q2
3 quarters
|
|
18
CVS Health
CVS
$112B
| $431M | 1% |
5,753,770
-242,616
| -4% | -$17.1M |
2013 Q2
3 quarters
|
|
19
Microsoft
MSFT
$4.01T
| $430M | 1% |
10,489,917
+703,799
| +7% | +$26.4M |
2013 Q2
3 quarters
|
|
20
Western Digital
WDC
$145B
| $428M | 1% |
6,160,961
-765,561
| -11% | -$50M |
2013 Q2
3 quarters
|
|
|
21
Baxter International
BAX
$12.8B
| $418M | 0.97% |
10,459,196
+1,396,713
| +15% | +$52.2M |
2013 Q2
3 quarters
|
|
|
DTV
22
DELISTED
DIRECTV COM STK (DE)
DTV
| $414M | 0.97% |
5,418,430
-129,123
| -2% | -$9.47M |
2013 Q2
3 quarters
|
|
|
LLL
23
DELISTED
L3 Technologies, Inc.
LLL
| $414M | 0.96% |
3,501,386
-101,537
| -3% | -$11.4M |
2013 Q2
3 quarters
|
|
|
AET
24
DELISTED
Aetna Inc
AET
| $410M | 0.96% |
5,472,074
-224,981
| -4% | -$15.9M |
2013 Q2
3 quarters
|
|
25
Marathon Petroleum
MPC
$129B
| $405M | 0.94% |
9,297,828
-180,078
| -2% | -$7.89M |
2013 Q2
3 quarters
|
|
Similar funds
HF
LSV Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, LSV Asset Management held 921 positions worth $42.9B, up 0.82% from $42.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
LSV Asset Management's Q1 2014 filing shows 30 new, 236 increased, 381 reduced and 55 closed positions. Its largest new stake was Chemed: 283,612 shares worth $25.4M. The largest sale was St Jude Medical, an estimated $189M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Energy.
- LSV Asset Management's largest Q1 2014 buy was Chemed: 283,612 shares worth $25.4M.
- LSV Asset Management added most to AT&T in Q1 2014, an estimated $516M increase.
- LSV Asset Management's biggest Q1 2014 reduction was St Jude Medical, cutting an estimated $189M.
- LSV Asset Management fully exited Harman International Industries in Q1 2014, selling an estimated $75.3M.
- LSV Asset Management's ten largest holdings make up 17% of its $42.9B portfolio in Q1 2014.
- LSV Asset Management opened 30 new positions and closed 55 in Q1 2014.
- LSV Asset Management's portfolio value rose 0.82% quarter-over-quarter to $42.9B.
Based on LSV Asset Management's 13F filing for Q1 2014, filed 29 Apr 2014.